Genetic variation for antibiotic persistence in escherichia coli

Evolution

Volumn 66, Issue 3, 2012, Pages 933-939

  Stewart, Balint ^a   Rozen, Daniel E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Antibiotic; Clonal variation; E. coli; Microbial evolution; Persister

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLONAL GROWTH; COLIFORM BACTERIUM; GENETIC VARIATION; PERSISTENCE; PHENOTYPE; SURVIVAL;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPARATIVE STUDY; ESCHERICHIA COLI; EVOLUTION; GENETIC VARIABILITY; GENETICS; MICROBIOLOGICAL EXAMINATION; ORGANISMAL INTERACTION; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; BIOLOGICAL EVOLUTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENETIC VARIATION; MICROBIAL INTERACTIONS; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84857688870     PISSN: 00143820     EISSN: 15585646     Source Type: Journal    
DOI: 10.1111/j.1558-5646.2011.01467.x     Document Type: Article

References (27)

1. Acar, M., J. Mettetal, and A. van Oudenaarden 2008. Stochastic switching as a survival strategy in fluctuating environments. Nat. Genet. 40:471-475.
2. Balaban, N., J. Merrin, R. Chait, L. Kowalik, and S. Leibler 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
3. Bigger, J. W. 1944. Treatment of staphylococcal infections with penicillin. Lancet ii:497-500.
4. Bubeck-Martinez, S. 2005. Immune evasion of the Lyme disease spirochetes. Front. Biosci. 10:873-878.
5. Davidson, C. J., and M. G. Surette 2008. Individuality in bacteria. Annu. Rev. Genet. 42:253-268.
6. De Groote, V. N., N. Verstraeten, M. Fauvart, C. I. Kint, A. M. Verbeeck, S. Beullens, P. Cornelis, and J. Michiels 2009. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 297:73-79.
7. Dhar, N., and J. D. McKinney 2007. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10:30-38.
8. Drawz, S., and R. Bonomo 2010. Three decades of beta-lactamase inhibitors. Clin. Microbiol. Rev. 23:160-201.
9. Goldstein, E. 1987. Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Am. J. Med. 82:3-17.
10. Handwerger, S., and A. Tomasz 1985. Antibiotic tolerance among clinical isolates of bacteria. Rev. Infect. Dis. 7:368-386.
11. Hansen, S., K. Lewis, and M. Vulic 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents Chemother. 52:2718-2726.
12. Harrison, J. J., W. D. Wade, S. Akierman, C. Vacchi-Suzzi, C. A. Stremick, R. J. Turner, and H. Ceri 2009. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 53:2253-2258.
13. Keren, I., N. Kaldalu, A. Spoering, Y. P. Wang, and K. Lewis 2004a. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett. 230:13-18.
14. Keren, I., D. Shah, A. Spoering, N. Kaldalu, and K. Lewis 2004b. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
15. Levin, B. R., and D. E. Rozen 2006. Opinion-non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4:556-562.
16. Lewis, K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56.
17. Luidalepp, H., A. Jõers, N. Kaldalu, and T. Tenson 2011. Age of inoculum strongly influences persister frequency and can mask the effects of mutations implicated in altered persistence. J. Bacteriol. 193:3598-3605.
18. Ochman, H., and R. Selander 1984. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157:690-693.
19. Peeling, R. W., and E. W. Hook 2006. The pathogenesis of syphilis: the Great Mimicker, revisited. J. Pathol. 208:224-232.
20. Shakil, S., R. Khan, R. Zarrilli, and A. Khan 2008. Aminoglycosides versus bacteria-a description of the action, resistance mechanism, and nosocomial battleground. J. Biomed. Sci. 15:5-14.
21. Shi, W. L., and Y. Zhang 2010. PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 65:1237-1242.
22. Singh, P., A. Schaefer, M. Parsek, T. Moninger, M. Welsh, and E. Greenberg 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762-764.
23. Spoering, A. L., M. Vulic, and K. Lewis 2006. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 188:5136-5144.
24. Täuber, M., M. Burroughs, U. Niemöller, H. Kuster, U. Borschberg, and E. Tuomanen 1991. Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae. J. Infect. Dis. 163:806-811.
25. Vazquez-Laslop, N., H. Lee, and A. A. Neyfakh 2006. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188:3494-3497.
26. Wiuff, C., and D. I. Andersson 2007. Antibiotic treatment in vitro of phenotypically tolerant bacterial populations. J. Antimicrob. Chemother. 59:254-263.
27. Wiuff, C., R. Zappala, R. Regoes, K. Garner, F. Baquero, and B. Levin 2005. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49:1483-1494.